Revolutionizing Drug Discovery AI-Driven Approaches to Personalized Medicine and Predictive Therapeutics
Authors
Super Admin
Not Provided
Abstract
By discovering and creating novel drugs to treat a range of illnesses, the discipline of drug discovery and development plays a vital role in healthcare. Conventional approaches to drug development have been costly, time-consuming, and frequently produce drugs that don't work for every patient. Precision medicine, on the other hand, seeks to customize medical care to each patient's unique needs while accounting for lifestyle, environment, and genetics. Artificial Intelligence (AI) has revolutionized drug discovery and development in recent years when it has become a potent instrument. Machine learning and deep learning are two examples of AI technologies that could drastically speed up medication discovery, lower prices, and increase treatment efficacy. Researchers can find possible therapeutic targets, create new compounds, and forecast patient response to treatment with the use of artificial intelligence (AI), which analyzes vast datasets and find patterns. This research investigates how AI can be used to find and produce drugs for precision medicine. With adding that, it gives a summary of the conventional drug discovery procedure, emphasizing its drawbacks. Later this research describes how AI technologies are being applied to solve these obstacles, with particular attention to how they are being employed in clinical trials, target identification and validation, and computational drug design. The research also looks at how AI may help to provide personalized medicine, in which each patient receives a customized course of therapy. In summary, this study attempts to present a thorough analysis of the state of AI-driven drug development today and how it can revolutionize precision medicine. Understanding the developments and difficulties in this field helps us to better grasp how AI may transform healthcare in the future and enhance patient outcomes.
Keywords
Submission Status
Submitted
2/25/2026
Manuscript received by editorial office.
Under Review
Review process initiated.
Editorial Decision
Pending final decision.
Published
2024-10-22
Available online.
